REGENXBIO Inc. (RGNX) revenue

Revenue · fiscal 2025
$170.44M

REGENXBIO Inc. (RGNX) reported revenue of $170.44M in fiscal 2025 (the year ended December 31, 2025). That is 104.5% higher than the $83.33M of fiscal 2024. Figures as of 18 Nov 2026, 11:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$170.44M
Change on fiscal 2024
+104.5%
Growth, 5 years
+2.0% a year
Growth, 10 years
+36.5% a year
Highest on record
$470.35Mfiscal 2021
Lowest on record
$4.59Mfiscal 2016
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

REGENXBIO Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 2.0% a year; over ten years the rate was 36.5% a year. Across the 13 fiscal years on record (2013–2025), the highest was $470.35M in fiscal 2021 and the lowest $4.59M in fiscal 2016.

History · 13 fiscal years

Revenue by fiscal year

REGENXBIO Inc. revenue, year by year

REGENXBIO Inc. (RGNX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$170.44M 104.5% up
2024$83.33M 7.7% down
2023$90.24M 19.9% down
2022$112.72M 76.0% down
2021$470.35M 204.3% up
2020$154.57M 338.7% up
2019$35.23M 83.9% down
2018$218.51M 2,002.4% up
2017$10.39M 126.5% up
2016$4.59M 39.5% down
2015$7.59M 24.0% up
2014$6.12M 0.5% up
2013$6.09M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on RGNX

REGENXBIO Inc., figure by figure

REGENXBIO Inc. (RGNX) overview: price, valuation and scorecard

REGENXBIO Inc. revenue: questions and answers

What is REGENXBIO Inc.'s revenue?

REGENXBIO Inc. (RGNX) reported revenue of $170.44M in fiscal 2025 (the year ended December 31, 2025). That is 104.5% higher than the $83.33M of fiscal 2024.

What is the growth rate of REGENXBIO Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 2.0% a year; over ten years the rate was 36.5% a year.

What are the highest and lowest revenue figures on record for REGENXBIO Inc.?

Across the 13 fiscal years on record (2013–2025), the highest was $470.35M in fiscal 2021 and the lowest $4.59M in fiscal 2016.

How is REGENXBIO Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For REGENXBIO Inc. it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “REGENXBIO Inc. (RGNX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RGNX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.